Track
:
Track 14: Clinical Safety and Pharmacovigilance
Program Code:
117
Date:
Monday, June 24, 2013
Time:
11:00 AM to 12:30 PM
EST
Location:
152
CHAIR
:
Michael A. Ibara, PharmD (SCHNON), Head of Business Development Coordination & Innovation, WW Safety & Regulatory, Pfizer Inc, United States
Dr. Michael Ibara is Head of Pharmacovigilance Information Mgt at Pfizer. His current focus is on pharmacovigilance, digital healthcare, eHealth and the possibility of improving public health through innovative approaches to pharmacovigilance.
SPEAKER
(S):
Jesus Rivera, MSc (SPKNON), Senior Learning Manager, Bristol-Myers Squibb Company, United States
Jesús has over 10 years of proven experience in the pharmaceutical industry diagnosing, planning and implementing training, organizational development and technology solutions addressing the learning needs of global research & development scientists as well as clinical trial investigators & staff.
Allison Salke, MBA (SPKNON), Tombolo, Inc., United States
Description
In recent years, pharmacovigilance has emphasized the collection and submission of tabular data. Using ideas from narrative medicine, we can re-focus on the patient's story to better understand adverse drug reactions and benefit-risk balance.